yingweiwo

New3

New3

New3 related products

Structure Cat No. Product Name CAS No. Product Description
Topoisomerase II inhibitor 6 V47352 Topoisomerase II inhibitor 6 2987586-62-7 Topoisomerase II inhibitor 6 (Compound 5) is a tryptophan analogue that is a potent and specific inhibitor of topoisomerase II.
Topoisomerase II inhibitor 7 V45849 Topoisomerase II inhibitor 7 2697171-03-0 Topoisomerase II inhibitor 7 (compound 3a) is a potent inhibitor of topoisomerase II α subtype with IC50 of 3.19 μM.
Topoisomerase II inhibitor 8 V46115 Topoisomerase II inhibitor 8 2493298-68-1 Topoisomerase II inhibitor 8 (compound 22) is a potent topoisomerase II inhibitor (antagonist) with IC50 of 0.52 μM.
Topoisomerase II inhibitor-10 V45620 Topoisomerase II inhibitor-10 2488208-96-2 Topoisomerase II inhibitor 10 (compound 32a) is a potent topoisomerase II inhibitor (antagonist) with IC50 of 7.45 μM.
Topoisomerase IIα-IN-1 V47378 Topoisomerase IIα-IN-1 2407521-87-1 Topoisomerase IIα-IN-1 (compound 2) is a potent inhibitor of DNA-binding ligands and topoisomerase TopoIIα.
Topoisomerase IIα-IN-2 V47353 Topoisomerase IIα-IN-2 2407521-90-6 Topoisomerase IIα-IN-2 (compound 5) is a potent inhibitor of DNA-binding ligands and topoisomerase TopoIIα.
Toremifene-d6 V48094 Toremifene-d6 Toremifene-d6 is thedeuterium labeled form of Toremifene (Z-Toremifene), which is a 2nd-generation selective estrogen-receptor modulator (SERM) for osteoporosis.
TP-0427736 HCl V49173 TP-0427736 HCl 2459963-17-6 TP0427736 HCl is a potent inhibitor of ALK5 kinase activity with IC50 of 2.72 nM, which is 300-fold greater than the inhibition of ALK3 (IC50 for ALK3 inhibition is 836 nM).
TP-0480066 V43557 TP-0480066 2245693-15-4 TP0480066 is a selective topoisomerase II inhibitor (antagonist) with IC50s of 1.10 and 62.89 nM for DNA gyrase and topo IV, respectively.
TP-5801 V43947 TP-5801 2574474-81-8 TP-5801 is an orally bioactive non-receptor tyrosine kinase (TNK1) inhibitor (IC50=1.40 nM) and displays anti-tumor activity.
TPB-15 V46764 TPB-15 2170347-69-8 TPB15 is an orally bioavailable inhibitor of Hh (Hedgehog) signaling.
TPBM V46150 TPBM 6466-43-9 TPBM is a potent estrogen receptor alpha (ERα) inhibitor (antagonist) with IC50 of 9 μM for 17β-estradiol (E2)-ERα.
TPX-0046 V41748 TPX-0046 TPX-0046, RET/SRC inhibitor
Trametinib-13C,d3 V48673 Trametinib-13C,d3 2712126-59-3 Trametinib-13C,d3 is a 13C- and deuterated-labeled trametinib.
trans-4’-Hydroxy CCNU Lomustine-d4 V48286 trans-4’-Hydroxy CCNU Lomustine-d4 trans-4'-Hydroxy CCNU Lomustine-d4 is the deuterium labelled form of trans-4'-Hydroxy CCNU Lomustine.
trans-Dihydro Tetrabenazine-d7 V48657 trans-Dihydro Tetrabenazine-d7 1217744-19-8 trans-Dihydro Tetrabenazine-d7 is (2S,3S,11bS)-3-Isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin -2-ol deuterated compounds.
trans-Hydroxy Glimepiride-d4 V48087 trans-Hydroxy Glimepiride-d4 2749985-37-1 trans-Hydroxy Glimepiride-d4 is the deuterium labelled form of trans-Hydroxy Glimepiride.
trans-N-Methyl-4-methoxyproline V43854 trans-N-Methyl-4-methoxyproline 131559-49-4 trans-N-Methyl-4-methoxyproline is a proline analogue extracted from the stems of Petiveria alliacea.
trans-Resveratrol 4’-O-β-D-glucuronide-d4 V48633 trans-Resveratrol 4’-O-β-D-glucuronide-d4 1420291-58-2 trans-Resveratrol 4'-O-β-D-glucuronide-d4 is the deuterium labelled form of Resveratrol-4'-OD-Glucuronide.
trans-Zeatin-d5 V48509 trans-Zeatin-d5 72963-19-0 trans-Zeatin-d5 is the deuterium labelled form of trans-Zeatin.
Contact Us